Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-26 @ 12:47 AM
Study NCT ID:
NCT00262860
Status:
COMPLETED
Last Update Posted:
2016-05-09
First Post:
2005-12-06
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Bortezomib and Gemcitabine Hydrochloride in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
Sponsor:
University of Rochester
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-04
Start Date Type:
None
Primary Completion Date:
2008-05
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2005-12-06
First Submit QC Date:
None
Study First Post Date:
2005-12-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2016-02-25
Results First Submit QC Date:
None
Results First Post Date:
2016-03-28
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-30
Last Update Post Date:
2016-05-09
Last Update Post Date Type:
ESTIMATED